{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T08:35:02Z","timestamp":1793781302817,"version":"4.6.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Science and Technique Project of Henan province","award":["222102310709"],"award-info":[{"award-number":["222102310709"]}]},{"name":"Henan Young and Middle aged Health Science and Technology Innovation Leading Talents Training Project","award":["YXKC2022002"],"award-info":[{"award-number":["YXKC2022002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Imaging"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>This study aims to introduce the concept of habitat subregions and construct an accurate prediction model by analyzing refined medical images, to predict lymph node metastasis (LNM) in patients with intrahepatic cholangiocarcinoma (ICC) before surgery, and to provide personalized support for clinical decision-making.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Clinical, radiological, and pathological data from ICC patients were retrospectively collected. Using information from the arterial and venous phases of multisequence CT images, tumor habitat subregions were delineated through the K-means clustering algorithm. Radiomic features were extracted and screened, and prediction models based on different subregions were constructed and compared with traditional intratumoral models. Finally, a lymph node metastasis prediction model was established by integrating the features of several subregional models, and its performance was evaluated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 164 ICC patients were included in this study, 103 of whom underwent lymph node dissection. The patients were divided into LNM- and LNM\u2009+\u2009groups on the basis of lymph node status, and significant differences in white blood cell indicators were found between the two groups. Survival analysis revealed that patients with positive lymph nodes had significantly worse prognoses. Through cluster analysis, the optimal number of habitat subregions was determined to be 5, and prediction models based on different subregions were constructed. A comparison of the performance of each model revealed that the Habitat1 and Habitat5 models had excellent performance. The optimal model obtained by fusing the features of the Habitat1 and Habitat5 models had AUC values of 0.923 and 0.913 in the training set and validation set, respectively, demonstrating good predictive ability. Calibration curves and decision curve analysis further validated the superiority and clinical application value of the model.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>This study successfully constructed an accurate prediction model based on habitat subregions that can effectively predict the lymph node metastasis of ICC patients preoperatively. This model is expected to provide personalized decision support to clinicians and help to optimize treatment plans and improve patient outcomes.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s40644-025-00842-8","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T05:43:33Z","timestamp":1740548613000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["To accurately predict lymph node metastasis in patients with mass-forming intrahepatic cholangiocarcinoma by using CT radiomics features of tumor habitat subregions"],"prefix":"10.1186","volume":"25","author":[{"given":"Pengyu","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenwei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peigang","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuochao","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingshan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianzhou","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,26]]},"reference":[{"issue":"1","key":"842_CR1","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41572-021-00300-2","volume":"7","author":"PJ Brindley","year":"2021","unstructured":"Brindley PJ, Bachini M, Ilyas SI, Khan SA, Loukas A, Sirica AE, Teh BT, Wongkham S, Gores GJ. Cholangiocarcinoma. Nat Rev Dis Primers. 2021;7(1):65.","journal-title":"Nat Rev Dis Primers"},{"issue":"28","key":"842_CR2","doi-asserted-by":"publisher","first-page":"3695","DOI":"10.3748\/wjg.v28.i28.3695","volume":"28","author":"CR Lin","year":"2022","unstructured":"Lin CR, Lee YK, Chiang CJ, Yang YW, Chang HC, You SL. Secular trends of intrahepatic cholangiocarcinoma in a high endemic area: a population-based study. World J Gastroenterol. 2022;28(28):3695\u2013705.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"842_CR3","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.jhep.2014.01.021","volume":"60","author":"J Bridgewater","year":"2014","unstructured":"Bridgewater J, Galle PR, Khan SA, Llovet JM, Park JW, Patel T, Pawlik TM, Gores GJ. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol. 2014;60(6):1268\u201389.","journal-title":"J Hepatol"},{"issue":"1","key":"842_CR4","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s11605-020-04557-y","volume":"25","author":"W RuiYang","year":"2021","unstructured":"RuiYang W, ZhiMing Y, Jiao F, Liang Z, Gang Z. Evaluation and recommendation of the 8th edition of American Joint Committee on Cancer (AJCC) staging system for Intrahepatic Cholangiocarcinoma (ICC) in 820 patients from the Surveillance, Epidemiology, and End Results (SEER) database. J Gastrointest Surg. 2021;25(1):145\u201354.","journal-title":"J Gastrointest Surg"},{"issue":"1","key":"842_CR5","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ejso.2021.08.009","volume":"48","author":"C Sposito","year":"2022","unstructured":"Sposito C, Droz dit Busset M, Virdis M, Citterio D, Flores M, Bongini M, Niger M, Mazzaferro V. The role of lymphadenectomy in the surgical treatment of intrahepatic cholangiocarcinoma: a review. Eur J Surg Oncol. 2022;48(1):150\u20139.","journal-title":"Eur J Surg Oncol"},{"issue":"7","key":"842_CR6","doi-asserted-by":"publisher","first-page":"8184","DOI":"10.1002\/cam4.5620","volume":"12","author":"J Zhu","year":"2023","unstructured":"Zhu J, Liu C, Li H, Ren H, Cai Y, Lan T, Wu H. Adequate lymph node dissection is essential for accurate nodal staging in intrahepatic cholangiocarcinoma: a population-based study. Cancer Med. 2023;12(7):8184\u201398.","journal-title":"Cancer Med"},{"key":"842_CR7","doi-asserted-by":"publisher","first-page":"1149211","DOI":"10.3389\/fonc.2023.1149211","volume":"13","author":"S Liao","year":"2023","unstructured":"Liao S, Liao R, Wu H, Wang S, Zhou Y. Proposal for a new N-stage classification system for intrahepatic cholangiocarcinoma. Front Oncol. 2023;13:1149211.","journal-title":"Front Oncol"},{"issue":"2","key":"842_CR8","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jhep.2019.10.009","volume":"72","author":"RK Kelley","year":"2020","unstructured":"Kelley RK, Bridgewater J, Gores GJ, Zhu AX. Systemic therapies for intrahepatic cholangiocarcinoma. J Hepatol. 2020;72(2):353\u201363.","journal-title":"J Hepatol"},{"issue":"4","key":"842_CR9","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1002\/hep.30289","volume":"69","author":"AE Sirica","year":"2019","unstructured":"Sirica AE, Gores GJ, Groopman JD, Selaru FM, Strazzabosco M, Wei Wang X, Zhu AX. Intrahepatic cholangiocarcinoma: continuing challenges and translational advances. Hepatology. 2019;69(4):1803\u201315.","journal-title":"Hepatology"},{"issue":"2","key":"842_CR10","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3322\/caac.21759","volume":"73","author":"D Moris","year":"2023","unstructured":"Moris D, Palta M, Kim C, Allen PJ, Morse MA, Lidsky ME. Advances in the treatment of intrahepatic cholangiocarcinoma: an overview of the current and future therapeutic landscape for clinicians. CA Cancer J Clin. 2023;73(2):198\u2013222.","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"842_CR11","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.7150\/ijbs.71046","volume":"18","author":"L Zhang","year":"2022","unstructured":"Zhang L, Wang Y, Peng Z, Weng Y, Fang Z, Xiao F, Zhang C, Fan Z, Huang K, Zhu Y, et al. The progress of multimodal imaging combination and subregion based radiomics research of cancers. Int J Biol Sci. 2022;18(8):3458\u201369.","journal-title":"Int J Biol Sci"},{"issue":"9","key":"842_CR12","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41568-018-0030-7","volume":"18","author":"RJ Gillies","year":"2018","unstructured":"Gillies RJ, Brown JS, Anderson ARA, Gatenby RA. Eco-evolutionary causes and consequences of temporal changes in intratumoural blood flow. Nat Rev Cancer. 2018;18(9):576\u201385.","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"842_CR13","doi-asserted-by":"publisher","first-page":"4187","DOI":"10.3390\/ijms23084187","volume":"23","author":"S Mancarella","year":"2022","unstructured":"Mancarella S, Serino G, Coletta S, Armentano R, Dituri F, Ardito F, Ruzzenente A, Fabregat I, Giannelli G. The tumor microenvironment drives intrahepatic cholangiocarcinoma progression. Int J Mol Sci. 2022;23(8):4187.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"842_CR14","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1080\/17474124.2021.1974294","volume":"15","author":"Q Li","year":"2021","unstructured":"Li Q, Che F, Wei Y, Jiang HY, Zhang Y, Song B. Role of noninvasive imaging in the evaluation of intrahepatic cholangiocarcinoma: from diagnosis and prognosis to treatment response. Expert Rev Gastroenterol Hepatol. 2021;15(11):1267\u201379.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"1","key":"842_CR15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s40644-020-00323-0","volume":"20","author":"MJ King","year":"2020","unstructured":"King MJ, Hectors S, Lee KM, Omidele O, Babb JS, Schwartz M, Tabrizian P, Taouli B, Lewis S. Outcomes assessment in intrahepatic cholangiocarcinoma using qualitative and quantitative imaging features. Cancer Imaging. 2020;20(1):43.","journal-title":"Cancer Imaging"},{"issue":"3","key":"842_CR16","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3390\/cancers13030445","volume":"13","author":"CM Kang","year":"2021","unstructured":"Kang CM, Suh KS, Yi NJ, Hong TH, Park SJ, Ahn KS, Hayashi H, Choi SB, Jeong CY, Takahara T, et al. Should lymph nodes be retrieved in patients with intrahepatic cholangiocarcinoma? A collaborative Korea-Japan study. Cancers. 2021;13(3):445.","journal-title":"Cancers"},{"issue":"12","key":"842_CR17","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrclinonc.2017.141","volume":"14","author":"P Lambin","year":"2017","unstructured":"Lambin P, Leijenaar RTH, Deist TM, Peerlings J, de Jong EEC, van Timmeren J, Sanduleanu S, Larue R, Even AJG, Jochems A, et al. Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol. 2017;14(12):749\u201362.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"842_CR18","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1002\/med.21846","volume":"42","author":"J Guiot","year":"2021","unstructured":"Guiot J, Vaidyanathan A, Deprez L, Zerka F, Danthine D, Frix AN, Lambin P, Bottari F, Tsoutzidis N, Miraglio B, et al. A review in radiomics: making personalized medicine a reality via routine imaging. Med Res Rev. 2021;42(1):426\u201340.","journal-title":"Med Res Rev"},{"key":"842_CR19","doi-asserted-by":"publisher","first-page":"1133867","DOI":"10.3389\/fonc.2023.1133867","volume":"13","author":"P Chen","year":"2023","unstructured":"Chen P, Yang Z, Zhang H, Huang G, Li Q, Ning P, Yu H. Personalized intrahepatic cholangiocarcinoma prognosis prediction using radiomics: application and development trend. Front Oncol. 2023;13:1133867.","journal-title":"Front Oncol"},{"issue":"8","key":"842_CR20","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.3390\/cancers14081858","volume":"14","author":"HH Cho","year":"2022","unstructured":"Cho HH, Kim H, Nam SY, Lee JE, Han BK, Ko EY, Choi JS, Park H, Ko ES. Measurement of perfusion heterogeneity within tumor habitats on magnetic resonance imaging and its association with prognosis in breast cancer patients. Cancers. 2022;14(8):1858.","journal-title":"Cancers"},{"key":"842_CR21","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.ebiom.2019.05.023","volume":"44","author":"C Xie","year":"2019","unstructured":"Xie C, Yang P, Zhang X, Xu L, Wang X, Li X, Zhang L, Xie R, Yang L, Jing Z, et al. Sub-region based radiomics analysis for survival prediction in oesophageal tumours treated by definitive concurrent chemoradiotherapy. EBioMedicine. 2019;44:289\u201397.","journal-title":"EBioMedicine"},{"issue":"1","key":"842_CR22","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.asjsur.2021.06.031","volume":"45","author":"F Yang","year":"2022","unstructured":"Yang F, Wu C, Bo Z, Xu J, Yi B, Li J, Qiu Y. The clinical value of regional lymphadenectomy for intrahepatic cholangiocarcinoma. Asian J Surg. 2022;45(1):376\u201380.","journal-title":"Asian J Surg"},{"issue":"6","key":"842_CR23","doi-asserted-by":"publisher","first-page":"e1187","DOI":"10.1097\/SLA.0000000000003788","volume":"274","author":"XF Zhang","year":"2021","unstructured":"Zhang XF, Xue F, Dong D-H, Weiss M, Popescu I, Marques HP, Aldrighetti L, Maithel SK, Pulitano C, Bauer TW, et al. Number and station of lymph node metastasis after curative-intent resection of intrahepatic cholangiocarcinoma impact prognosis. Ann Surg. 2021;274(6):e1187\u201395.","journal-title":"Ann Surg"},{"issue":"1","key":"842_CR24","doi-asserted-by":"publisher","first-page":"12691","DOI":"10.1038\/s41598-022-16727-w","volume":"12","author":"D Liu","year":"2022","unstructured":"Liu D, Heij LR, Czigany Z, Dahl E, Dulk MD, Lang SA, Ulmer TF, Neumann UP, Bednarsch J. The prognostic value of neutrophil-to-lymphocyte ratio in cholangiocarcinoma: a systematic review and meta-analysis. Sci Rep. 2022;12(1):12691.","journal-title":"Sci Rep"},{"issue":"1","key":"842_CR25","doi-asserted-by":"publisher","first-page":"33789","DOI":"10.1038\/srep33789","volume":"6","author":"DW Tan","year":"2016","unstructured":"Tan DW, Fu Y, Su Q, Guan MJ, Kong P, Wang SQ, Wang HL. Prognostic significance of neutrophil to lymphocyte ratio in oncologic outcomes of cholangiocarcinoma: a meta-analysis. Sci Rep. 2016;6(1):33789.","journal-title":"Sci Rep"},{"issue":"6","key":"842_CR26","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.surg.2019.06.005","volume":"166","author":"F Bagante","year":"2019","unstructured":"Bagante F, Spolverato G, Merath K, Weiss M, Alexandrescu S, Marques HP, Aldrighetti L, Maithel SK, Pulitano C, Bauer TW, et al. Intrahepatic cholangiocarcinoma tumor burden: a classification and regression tree model to define prognostic groups after resection. Surgery. 2019;166(6):983\u201390.","journal-title":"Surgery"},{"issue":"4","key":"842_CR27","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1007\/s12072-022-10477-7","volume":"17","author":"H Rhee","year":"2023","unstructured":"Rhee H, Lim HJ, Han K, Yeom SK, Choi SH, Park JH, Cho ES, Park S, Lee MJ, Choi GH, et al. A preoperative scoring system to predict lymph node metastasis in intrahepatic cholangiocarcinoma. Hep Intl. 2023;17(4):942\u201353.","journal-title":"Hep Intl"},{"issue":"1","key":"842_CR28","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1186\/s12885-022-10025-4","volume":"22","author":"T Huang","year":"2022","unstructured":"Huang T, Liu H, Lin Z, Kong J, Lin K, Lin Z, Chen Y, Lin Q, Zhou W, Li J, et al. Preoperative prediction of intrahepatic cholangiocarcinoma lymph node metastasis by means of machine learning: a multicenter study in China. BMC Cancer. 2022;22(1):931.","journal-title":"BMC Cancer"},{"issue":"7","key":"842_CR29","doi-asserted-by":"publisher","first-page":"3725","DOI":"10.1007\/s00330-019-06142-7","volume":"29","author":"GW Ji","year":"2019","unstructured":"Ji GW, Zhu FP, Zhang YD, Liu XS, Wu FY, Wang K, Xia YX, Zhang YD, Jiang WJ, Li XC, et al. A radiomics approach to predict lymph node metastasis and clinical outcome of intrahepatic cholangiocarcinoma. Eur Radiol. 2019;29(7):3725\u201335.","journal-title":"Eur Radiol"},{"issue":"18","key":"842_CR30","doi-asserted-by":"publisher","first-page":"5374","DOI":"10.7150\/thno.34149","volume":"9","author":"L Xu","year":"2019","unstructured":"Xu L, Yang P, Liang W, Liu W, Wang W, Luo C, Wang J, Peng Z, Xing L, Huang M, et al. A radiomics approach based on support vector machine using MR images for preoperative lymph node status evaluation in intrahepatic cholangiocarcinoma. Theranostics. 2019;9(18):5374\u201385.","journal-title":"Theranostics"},{"issue":"11","key":"842_CR31","doi-asserted-by":"publisher","first-page":"6786","DOI":"10.1245\/s10434-022-12028-8","volume":"29","author":"S Zhang","year":"2022","unstructured":"Zhang S, Huang S, He W, Wei J, Huo L, Jia N, Lin J, Tang Z, Yuan Y, Tian J, et al. Radiomics-based preoperative prediction of lymph node metastasis in intrahepatic cholangiocarcinoma using contrast-enhanced computed tomography. Ann Surg Oncol. 2022;29(11):6786\u201399.","journal-title":"Ann Surg Oncol"}],"container-title":["Cancer Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-025-00842-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40644-025-00842-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-025-00842-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T05:43:38Z","timestamp":1740548618000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerimagingjournal.biomedcentral.com\/articles\/10.1186\/s40644-025-00842-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,26]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["842"],"URL":"https:\/\/doi.org\/10.1186\/s40644-025-00842-8","relation":{},"ISSN":["1470-7330"],"issn-type":[{"value":"1470-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,26]]},"assertion":[{"value":"4 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research adhered to the principles of the Declaration of Helsinki and was approved by the ethics committees of the People\u2019s Hospital of Henan University and Henan Cancer Hospital (Ref No. 2023\u2013012 and Ref No. 2023\u2013203).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors consented to the submission of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19"}}